XIST, LINC00173, FBN1, COL1A1, COL5A1, and BGN were identified as key molecules in the network, which have potential diagnostic value and may be therapeutic targets for ARVC. The gene discussed is COL5A1; the disease is Arrhythmogenic right ventricular dysplasia.